Linezolid: Difference between revisions
GregArmani (talk | contribs) (→Common) |
GregArmani (talk | contribs) |
||
| Line 23: | Line 23: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*[[Serotonin syndrome]] can be caused with concomitant use with an SSRI or MAOI | |||
*Myelosuppression can occur after two week of use | |||
*Peripheral and optic neuropathy | |||
*[[Lactic acidosis]] | |||
===Common=== | ===Common=== | ||
Revision as of 02:20, 24 October 2015
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Serotonin syndrome can be caused with concomitant use with an SSRI or MAOI
- Myelosuppression can occur after two week of use
- Peripheral and optic neuropathy
- Lactic acidosis
Common
- GI upset
- Headache
- Fever
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
Source
- ↑ Sanford Guide to Antimicrobial Therapy 2014
